-
Active Stocks At Healthcare: UnitedHealth Group Inc. (NYSE:UNH), Mylan Inc (NASDAQ:MYL), AbbVie Inc (NYSE:ABBV), Teva Pharmaceutical Industries (NYSE:TEVA)
UnitedHealth Group Inc. (NYSE:UNH) told investors that during the first quarter, it saw “intensified pricing in several markets, including small group in New York, a large market for us,” according to CEO Stephen Hemsley. Speaking during an April 17 conference call to discuss first-quarter 2014 financial results, he said, “We believe several carriers there, including…
-
Drug Manufacturer Most Active Stocks: Pfizer Inc. (NYSE:PFE), Eli Lilly (NYSE:LLY), Merck & Co (NYSE:MRK), AbbVie Inc (NYSE:ABBV)
Actavis PLC and Pfizer Inc. (NYSE:PFE) said they settled all patent litigation over the generic version of painkiller Celebrex, which may allow Actavis to start marketing its version before the end of the year. Shares of Pfizer Inc. (NYSE:PFE)closed at $30.71 in last trading session. Yesterday share price of the company was traded in the…
-
Drug Manufacturer – Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), AbbVie Inc (NYSE:ABBV), Keryx Biopharmaceuticals (NASDAQ:KERX)
A potential Pfizer Inc. (NYSE:PFE) treatment for an advanced form of lung cancer missed its main goals in two late-stage studies, but the drugmaker said it is still waiting for results from a third study. The New York company said Monday that dacomitinib failed to show a statistically significant improvement in progression-free survival in a…
-
AbbVie Inc (NYSE:ABBV) Q3 Boost Due To Sale of Its Humira Drug
AbbVie Inc (NYSE:ABBV) third quarter earnings beat analyst’s predictions due to increase in sale of its Humira drug. The US based drug-manufacture that in January split from Abbott Laboratories (NYSE:ABT) also increased the lower end of its complete-year prediction. The drug maker earning after excluding one-time items were declared as 82 cents per share beat…
-
Drug Maker In Pressure: Merck & Co., Inc. (NYSE:MRK) Face Lawsuit of $100 million
A sales person for Merck & Co., Inc. (NYSE:MRK) filed court case of overi$100M sex discrimination against the drugmaker, asserting that it mainly distinguishes alongside pregnant employees and women among children. In a claim filed in U.S. District Court in New Jersey, the claimant, Kelli Smith asserts she was downgraded for taking maternity leave in…